Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Karius
Karius is a clinical metagenomics company that leverages genomics and AI to advance infectious disease diagnostics. Founded in 2014 and headquartered in Redwood City, California, Karius operates a…
Karius
Karius is a clinical metagenomics company that leverages genomics and AI to advance infectious disease diagnostics. Founded in 2014 and headquartered in Redwood City, California, Karius operates a…
TL;DR
Founded: 2014
Headquarters: Redwood City, California
Core product: Karius Test — microbial cell-free DNA liquid biopsy for infectious-disease diagnosis
Laboratory: CLIA-certified and CAP-accredited high-complexity clinical laboratory
Recent financing: Series C announced May 2, 2024 ($100M)
Company Overview
Problem Domain
Infectious disease diagnostics and microbial detection using genomic sequencing and AI.
Founded
2014
Industry
Biotechnology Research
Tech Stack
Funding Track Record
100000000
Series C announced May 2, 2024
165000000
Large financing announced February 24, 2020
Investor Signal
“Backed by multiple prominent life-sciences and venture investors including Khosla Ventures, 5AM Ventures, Gilde Healthcare, SoftBank Vision Fund, General Catalyst, HBM Healthcare Investments, Khosla Ventures, Lightspeed Venture Partners, Tencent, and others”
